A novel approach for classifying patients with adrenal tumors based on decision support systems and artificial intelligence.
Journal:
Hormones (Athens, Greece)
Published Date:
Jun 30, 2025
Abstract
AIMS: Adrenal incidentalomas (AIs) encompass a wide range of clinical entities, from incidental benign neoplasms that need to be monitored to aggressive malignancies requiring urgent medical intervention and treatment. The incidence of adrenal tumors is steadily rising, reflecting a growing trend in their prevalence and highlighting the necessity for heightened awareness and advanced diagnostic strategies to address this escalating health concern. This retrospective study was undertaken in order to explore the possibility of developing a decision support system for classifying adrenal tumors as benign and malignant or suspicious for malignancy.
Authors
Keywords
No keywords available for this article.